DPP4 and type 2 diabetes mellitus: SIT, one orally stable effective and selective DPP-4 inhibitor (one tablet a day for T2DM), has been manifested effective control on blood sugar, as well as on mass and function of the islets, and no significant side effects (Aston-Mourney et al., 2013).